INTCO MEDICAL(SZ:300677) Xin Lang Cai Jing·2025-11-24 02:18Group 1 - The core viewpoint of the news is that Yingke Medical has seen a 5% increase in stock price, reaching 40.50 CNY per share, with a trading volume of 267 million CNY and a turnover rate of 1.43%, resulting in a total market capitalization of 26.519 billion CNY [1] - Yingke Medical Technology Co., Ltd. is located in Zibo City, Shandong Province, and was established on July 20, 2009, with its listing date on July 21, 2017. The company operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] Group 2 - From the perspective of major fund holdings, one fund under the Fortune Fund has a significant position in Yingke Medical. The Fortune CSI Pharmaceutical Theme Index Enhanced Fund (LOF) A (161035) held 193,700 shares in the third quarter, accounting for 1.79% of the fund's net value, ranking as the ninth largest holding. The estimated floating profit today is approximately 373,800 CNY [2] - The Fortune CSI Pharmaceutical Theme Index Enhanced Fund (LOF) A (161035) was established on November 11, 2016, with a current scale of 353 million CNY. Year-to-date returns are 15.91%, ranking 2658 out of 4208 in its category; the one-year return is 10.07%, ranking 2920 out of 3981; and since inception, the return is 41.07% [2] Group 3 - The fund managers of the Fortune CSI Pharmaceutical Theme Index Enhanced Fund (LOF) A (161035) are Niu Zhidong and Cai Kaer. As of the report, Niu Zhidong has a tenure of 10 years and 199 days, managing assets totaling 24.849 billion CNY, with the best fund return during his tenure being 111.51% and the worst being -88.81%. Cai Kaer has a tenure of 8 years and 325 days, managing assets totaling 111.894 billion CNY, with the best return of 51.06% and the worst of -32.1% [3]